Back to results
RecruitingPhase 2

FUSCC Refractory TNBC Platform Study (FUTURE2.0)

NCT05749588

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fudan University Shanghai Cancer Center

Shanghai, China

View on ClinicalTrials.gov
FUSCC Refractory TNBC Platform Study (FUTURE2.0) — TrialFind